Status:
TERMINATED
Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Vitiligo
Eligibility:
All Genders
18-89 years
Phase:
PHASE2
PHASE3
Brief Summary
Vitiligo is an autoimmune cutaneous disorder that destroys melanocytes leading to depigmented areas of skin. In the United States, vitiligo affects 1% of patients, causing not only changes in the colo...
Eligibility Criteria
Inclusion
- 1\. Patients with 3 or more localized patches of stable vitiligo
- 2\. No prior treatment or had failed previous vitiligo treatments
Exclusion
- 1\. Unstable vitiligo
- 2\. Allergic to triamcinolone
- 3\. Systemic treatments
- 4\. Pregnancy
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT02191748
Start Date
September 1 2014
End Date
January 1 2018
Last Update
July 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RWJUH Dermatology office
Somerset, New Jersey, United States, 08873